Express Pharma - Page 5 of 2206 - Express Pharma

From packaging to patient outcomes: Why India’s latest DPCO amendment signals a new direction for pharmaceutical care

DoP amends DPCO 2013 to ease compliance, clarify overcharging liability

Draft National Pharmacy Commission Bill proposes sweeping overhaul of pharmacy education and regulation

From fintech to aesthetic injectables: Lessons in navigating regulatory formalisation

Karnataka holds 64th Vision Group on Biotechnology meeting to review biotech ecosystem

Glenmark launches Methylene Blue Injection USP in US

ILAMED expands international presence with centres in Kenya, Ethiopia and Thailand

Novartis India launches Pluvicto for PSMA-positive metastatic prostate cancer

Alembic receives USFDA final approval for Tretinoin Cream USP, 0.05%

Ipca Laboratories and Bhami’s Research Laboratory signs global licensing agreement for subcutaneous biologics platform

CDSCO’s cosmetic regulations: The rules exist. The enforcement does not

Why ingredient transparency matters more than ever in cosmeceuticals

Indore Pharma Summit: Mapping the future of India pharma